MLTX FY 2025 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$245M

Net Income

-$227M

EPS (Diluted)

$-3.53

Cash Flow

Operating Cash Flow

-$196M

Free Cash Flow

-$196M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$424M

Total Liabilities

$120M

Stockholders' Equity

$304M

Cash & Equivalents

$335M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	$0	—
Operating Income	-$245M	-$143M	-71.1%
Net Income	-$227M	-$119M	-91.1%